SINGAPORE – The private equity specialist credited with transforming Singapore-based Fullerton Healthcare Corp (FHC) into an Asia-Pacific healthcare management firm is embroiled in a legal spat with his two partners in relation to its potential billion-dollar equity sale.
Mr David Sin, a co-founder, group president and executive director of FHC, is suing co-founders and minority shareholders Michael Tan and Daniel Chan, two former Parkway doctors.
Please subscribe or log in to continue reading the full article.
Get unlimited access to all stories at $0.99/month
- Latest headlines and exclusive stories
- In-depth analyses and award-winning multimedia content
- Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*
*Terms and conditions apply.